# Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)

> **NCT02739542** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 87 (actual)

## Conditions studied

- Multiple Sclerosis (MS)

## Interventions

- **DRUG:** Tecfidera
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02739542
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-19
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2022-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02739542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02739542, "Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02739542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*